Publications

5674 Results

The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831

Authors
EA Perez;F Baehner;S Butler;EA Thompson;A Dueck;F Jamshidian;D Cherbavaz;C Yoshizawa;S Shak;P Kaufman;N Davidson;J Gralow;Y Asmann;K Ballman
Journal / Conference
Breast Cancer Research, Oct 1;17(1):133
Year
2015
Research Committee(s)
Breast
PMID
PMID26429296
PMC
PMC4589954
Study Number(s)
N9831

Effect of 5a-reductase inhibitor use on mortality from prostate cancer [Editorial/Commentary]

Authors
W Figg;I Thompson
Journal / Conference
JAMA Oncology, Jun;1(3):321-322
Year
2015
Research Committee(s)
Cancer Control
PMID
PMID26181178
PMC
PMC n/a
Study Number(s)
SWOG-9217

Predicting low accrual in the National Cancer Institute's Cooperative Group Clinical Trials

Authors
CS Bennette;SD Ramsey;CL McDermott;JJ Carlson;A Basu;D Veenstra
Journal / Conference
Journal of the National Cancer Institute 108(2). pii: djv324. doi: 10.1093/jnci/djv324.
Year
2015
Research Committee(s)
Cancer Care Delivery
PMID
PMID26714555
PMC
PMC5964887

Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies

Authors
T Key;P Appelby;R Travis;D Albanes;A Alberg;A Barricarte;A Black;H Boeing;H Bas Bueno-de-Mesquita;J Chan;C Chen;MB Cook;JL Donovan;P Galan;R Gilbert;G Giles;E Giovannucci;G Goodman;P Goodman;MJ Gunter;FC Hamdy;M Heliovaara;KJ Helzlsouer;BE Henderson;S Hercberg;J Hoffman-Bolton;RN Hoover;M Johansson;K-T Khaw;IB King;P Knekt;LN Kolonel;L Le Marchand;S Mannisto;RM Martin;HE Meyer;AM Mondul;KA Moy;DE Neal;M Neuhouser;D Palli;EA Platz;C Pouchieu;H Rissanen;JM Schenk;G Severi;MJ Stempfer;A Tjonneland;M Touvier;A Trichopoulou;SJ Weinstein;R Ziegler;C Zhou;NE Allen
Journal / Conference
American Journal of Clinical Nutrition, Nov;102(5):1142-1157
Year
2015
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID26447150
PMC
PMC4625592
Study Number(s)
SWOG-9217

Two susceptibility loci identified for prostate cancer aggressiveness. [PJ Goodman and EA Klein, Collaborators, African Ancestry Prostate Cancer GWAS Consortium].

Authors
S Berndt;Z Wang;M Yeager
Journal / Conference
Nature Communications May 5;6:6889
Year
2015
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID25939597
PMC
PMC4422072
Study Number(s)
S0000

ALCHEMIST trials: a golden opportunity to transform outcomes in early-stage non-small cell lung cancer

Authors
R Govindan;S Mandrekar;D Gerber;G Oxnard;S Dahlberg;J Chaft;S Malik;M Mooney;J Abrams;P Janne;D Gandara;S Ramalingam;E Vokes
Journal / Conference
Clinical Cancer Research Dec 15;21(24):5439-44
Year
2015
Research Committee(s)
Lung
PMID
PMID26672084
PMC
PMC4683399
Study Number(s)
CTSU/E4512

Losing "Losing the Battle With Cancer" [Opinion]

Authors
L Ellis;CD Blanke;N Roach
Journal / Conference
JAMA Oncology Apr;1(1):13-14
Year
2015
Research Committee(s)
Cancer Care Delivery
PMID
PMID26182295

Long-term survival as a treatment benchmark in melanoma: latest results and clinical implications

Authors
KF Grossmann;K Margolin
Journal / Conference
Therapeutic Advances in Medical Oncology May;7(3):181-191
Year
2015
Research Committee(s)
Melanoma
PMID
PMID26673806
PMC
PMC4406913
Study Number(s)
S0008, S1404, SWOG-9430

Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer

Authors
MD Mason;W Parulekar;MR Sydes;M Brundage;P Kirkbride;M Gospodarowicz;R Cowan;EC Kostashuk;J Anderson;GP Swanson;MK Parmar;C Hayter;G Jovic;A Hiltz;J Hetherington;J Sathya;JB Barber;M McKenzie;S El-Sharkawi;L Souhami;PD Hardman;BE Chen;P Warde
Journal / Conference
Journal of Clinical Oncology Jul 1;33(19):2143-2150; Epub 2015 Feb 17
Year
2015
Research Committee(s)
Genitourinary
PMID
PMID25691677
PMC
PMC4477786
Study Number(s)
JPR3

Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase III randomized clinical trial

Authors
C Allegra;MJ O'Connell;G Yothers;R Beart;TF Wozniak;H Pitot;A Shields;J Landry;D Ryan;A Arora;LS Evans;N Bahary;G Soori;JF Eakle;JM Robertson;DF Moore;M Mullane;BT Marchello;PJ Ward;S Sharif;N Wolmark
Journal / Conference
Journal of the National Cancer Institute Sep 14;107(11). pii: djv248. doi: 10.1093/jnci/djv248. Print 2015 Nov
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID26374429
PMC
PMC4849360